A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 952
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CDAI
Long Form : Crohn's Disease Activity Index
No. Year Title Co-occurring Abbreviation
2020 A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis. AUROC, IR, MBDA, RA, SDAI
2020 A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition. DAS28, ESR, OMERACT, RA, RAPID3, SDAI, SJC
2020 A prospective study comparing patient-reported outcomes in Crohn's disease. BSFS, CRP, HBI, VAS
2020 Adalimumab for maintenance of remission in Crohn's disease. 6-MP, AEs, CD, RCTs, RRs, TNF-alpha
2020 Adaptation and validation of an Arabic version of a 10-item patient-reported outcome measure of physical function in rheumatoid arthritis. DAS28-ESR, HAQ-DI, RA
2020 Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss. IPAQ, MFIS
2020 Are key cytokines genetic and serum levels variations related to rheumatoid arthritis clinical severity? CBA, RA
2020 Assessment of bioelectrical phase angle as a predictor of nutritional status in patients with Crohn's disease: A cross sectional study. BC, CD, FFM, HGS, PhA
2020 Association between Health-Related Quality of Life and Nutritional Status in Adult Patients with Crohn's Disease. CD, HGS, HRQoL, SF
10  2020 Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial. ADSC, IBDQ, PDAI, VAS
11  2020 Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis. AVERT, MRI, MTX, RA, SDAI, SDAI
12  2020 Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study. IQR, SDAI, SLE
13  2020 Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits. ACR, HAQ-II, MDHAQ, PAS-II, RA, RAPID3, SDAI
14  2020 Can inflammatory markers and clinical indices serve as useful referral criteria for leukocyte scan with inflammatory bowel disease? CD, CRP, HBI, IBD, IM, TWC, UC, WBCs
15  2020 Cannabis for the Treatment of Inflammatory Bowel Disease: A True Medicine or a False Promise? IBD
16  2020 Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis. CV, ERS-RA, FU, RA, RRS, SCORE
17  2020 Circadian rhythm abnormalities in patients with inflammatory bowel disease - association with adipokine profile. CD, IBD, PSQI, UC
18  2020 Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis. AEs, DAS, IGU, MTX, RA, SDAI
19  2020 Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease. CD, CI, HR, ITT, NOS, RCTs, RR
20  2020 Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study. bDMARDs, RA, TNFi, tsDMARDs
21  2020 Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease. CD, CECDAI, LS, SBCE
22  2020 Conversion among the 28-joint count activity indices for rheumatoid arthritis. RA, SDAI
23  2020 Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. CD, PRO2, SES-CD, SF
24  2020 Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission. RA, SDAI
25  2020 Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study. MTX, RA, TCZ
26  2020 Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis. ACPA, IQR, LVSF, RA, sc-MFS
27  2020 Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjogren's syndrome enrolled in a large observational US registry. PROs, PSM, RA, SS
28  2020 Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients. NinJa, RA
29  2020 Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales? ADL, AIMS, EUA, PI, RA, TNF
30  2020 Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology. bDMARDs, cs, RA, RISE
31  2020 Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study. CZP, HAQ-DI, LDA, RA
32  2020 Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. HAQ-DI
33  2020 Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial. AEs, bDMARD, csDMARDs, RA
34  2020 Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease. CD, EEN
35  2020 Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors. IGU, TCZ, TNFi
36  2020 Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis. BMI, CCP, EHR, RA, RF, TNFi
37  2020 Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis. DAMs, DAS28, MTC, RA, RAPID3, VARA
38  2020 Evaluation of nutritional adequacy in adult patients with Crohn's disease: a cross-sectional study. CD, DRVs
39  2020 Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn's disease: the Indian experience. anti-TNF, CD, EEN
40  2020 Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease. CD, CRP, Fcal, SES-CD
41  2020 Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease. FC, HRQoL, IBD, IBDQ, IFX, pMayo
42  2020 Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. CI, DMARDs, ICI, IQR, PFS, RA
43  2020 Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis. ACPA, OPAL, RA, TNFi
44  2020 Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab. CRP, MTX, RA, RTX, TCZ
45  2020 Influence of Ambient Air Pollution on Rheumatoid Arthritis Disease Activity Score Index. DAS28, K-EPA, KRRD, MICE, RA
46  2020 Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. DAPSA, MDA, PASDAS, PsA, VLDA
47  2020 Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients? DAS28, MHAQ, SDAI
48  2020 Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM). ACR/EULAR, BIODAM, RA, SDAI
49  2020 Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study. RA
50  2020 Major Therapeutic Changes Have the Potential to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans with Rheumatoid Arthritis. DAMs, DAS28, MTC, RA, RAPID3, VARA
51  2020 Metabolic Syndrome In Young Rheumatoid Arthritis Patients. ---
52  2020 Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry. MTX, PROs, RA, TCZ
53  2020 Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study. GHAS, RHI, SES-CD
54  2020 Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. DAPSA, MDA, PASDAS, PsA, SDAI, VLDA
55  2020 Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. DAS28, HDA, LDA, MDA, mTSS, SDAI
56  2020 Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. HBI, NSQIP-SRC, SES-CD
57  2020 Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis. IL-6, mHAQ, RA, TNF, VAS
58  2020 Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab. CI, OR, RA
59  2020 Prevalence of cervical spine instability among Rheumatoid Arthritis patients in South Iraq. AAS, RA, SAS, SMO
60  2020 Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis. CRP, HAQ-DI, LTE, PGA, PtGA, RA, VAS
61  2020 Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis. IR, MR, RA
62  2020 Regulatory T cells in Crohn's disease following anti-TNF-alpha therapy. CD, CRP, FACS, TNF-alpha
63  2020 Relationship Between Vitamin D Deficiency and Disease Activity in Patients with Inflammatory Bowel Disease in Ahvaz, Iran. CD, IBD, UC
64  2020 Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial. DAS28-ESR, DMARDs, LDA, RA, RCI
65  2020 Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study. AUC, CD, ChE, HCs, IBD, SCCAI, UC
66  2020 Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. DAS28-CRP-3, RA, SDAI
67  2020 Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn's disease. CD, PGA, sHE, sLE, VAS
68  2020 Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice. mTSS, RA
69  2020 Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naive Crohn's Disease: A Case Series. AMAT, CD
70  2020 The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). AmE, AmE-FLARE-RA, FLARE-RA, RA, RAPID3, TJC, VAS
71  2020 The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis - a cross-sectional study. CRP, ESR, RA
72  2020 The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status. PESS, RAID, SDAI
73  2020 The periodontal inflamed surface area is associated with the clinical response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a retrospective study. bDMARDs, PISA, RA
74  2020 The Validity and Sensitivity of Rheumatoid Arthritis Pain Scale on a Different Ethnic Group From Indian Rheumatoid Arthritis Patients. DAS28, RA, RAPS
75  2020 Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results From an Interrupted Time Series Study. EHRs, health-IT, RA
76  2020 Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI Registries. anti-TNF, BioTRAC, EULAR, LDA, OBRI, RA
77  2020 Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis. MBDA, MSUS, RA
78  2020 Universal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients. GEE, RA
79  2020 Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease. CD, CRP, CT, FC, p.o, TNF, VD
80  2020 Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease. ROC, TNF
81  2020 Using process improvement and systems redesign to improve rheumatology care quality in a safety net clinic. LTBI, RA
82  2020 Validity and responsiveness of the Work Functioning Impairment Scale (WFun) in rheumatoid arthritis patients: A multicenter prospective study. HAQ-DI, RA, SDAI, WFun, WPAI
83  2020 [Study of the correlation between vitamin D status and cytokine levels in patients with Crohn's disease]. CD, IL-6, IL-8, TNF-alpha
84  2020 [Thalidomide in refractory Crohn's disease: long-term efficacy and safety]. CD, HR
85  2020 [The association between mesenteric fat hypertrophy and behavior and activity of Crohn's disease]. CD, SES-CD, US
86  2019 Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure. AUC, CRP, IFX
87  2019 Adalimumab for induction of remission in Crohn's disease. AEs, CD, RCTs, RR, SAEs
88  2019 Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease. AE, CD, RR, SAE
89  2019 Antibiotics for induction and maintenance of remission in Crohn's disease. AEs, anti-TNF, CD, MD, RCTs, RR
90  2019 Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease. ADC, CD, ES-CD
91  2019 Association of Serum Tocilizumab Trough Concentrations with Clinical Disease Activity Index Scores in Adult Patients with Rheumatoid Arthritis. BMI, GEE, RA, s.c, TCZ
92  2019 Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis. BMI, DAS28, EULAR, LDA, RA, TCZ
93  2019 Certolizumab pegol for induction of remission in Crohn's disease. CD, CZP, RR
94  2019 Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-alpha inhibitor in Crohn disease patients. CD, CRP, ELISA, HCs, IFX, IL, JNK, TNF
95  2019 Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values. APR, CRP, ESR, HAQ-DI, KORONA, RA
96  2019 Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry. ACPAs, bDMARDs, RA, TNFis
97  2019 Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment. CD, GHAS, MH, SES-CD
98  2019 Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis. MBDA, RA, RAPID3, SDAI
99  2019 Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry. CD
100  2019 Cytokines (IL-15, IL-21, and IFN-gamma) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity. CS, DAS28-ESR, RA, SDAI